Gorlin-Goltz综合征:PTCH1基因测序的病例报告和文献综述。

IF 1.3 Q3 SURGERY
Archives of Plastic Surgery-APS Pub Date : 2023-08-02 eCollection Date: 2023-07-01 DOI:10.1055/a-2096-3536
Hyo Seong Kim, Seung Heo, Kyung Sik Kim, Joon Choi, Jeong Yeol Yang
{"title":"Gorlin-Goltz综合征:PTCH1基因测序的病例报告和文献综述。","authors":"Hyo Seong Kim,&nbsp;Seung Heo,&nbsp;Kyung Sik Kim,&nbsp;Joon Choi,&nbsp;Jeong Yeol Yang","doi":"10.1055/a-2096-3536","DOIUrl":null,"url":null,"abstract":"<p><p>Gorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome, is an autosomal dominant disease characterized by multisystemic developmental defects caused by <i>pathogenic variants such as patched-1</i> ( <i>PTCH1</i> ) gene variants and/or SUFU gene variants. The presence of either two main criteria or one major and two minor criteria are required for the diagnosis of Gorlin-Goltz syndrome. Recently, a major criterion for molecular confirmation has also been proposed. In this article, we report the case of an 80-year-old male who was admitted at our department for multiple brown-to-black papules and plaques on the entire body. He was diagnosed with Gorlin-Goltz syndrome with clinical, radiologic, and pathologic findings. While the diagnosis was made based on the clinical findings in general, confirmation of the genetic variants makes an ideal diagnosis and suggests a new treatment method for target therapy. We requested a genetic test of PTCH1 to ideally identify the molecular confirmation in the hedgehog signaling pathway. However, no pathogenic variants were found in the coding region of PTCH1, and no molecular confirmation was achieved.</p>","PeriodicalId":47543,"journal":{"name":"Archives of Plastic Surgery-APS","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411172/pdf/","citationCount":"0","resultStr":"{\"title\":\"Gorlin-Goltz Syndrome: A Case Report and Literature Review with <i>PTCH1</i> Gene Sequencing.\",\"authors\":\"Hyo Seong Kim,&nbsp;Seung Heo,&nbsp;Kyung Sik Kim,&nbsp;Joon Choi,&nbsp;Jeong Yeol Yang\",\"doi\":\"10.1055/a-2096-3536\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Gorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome, is an autosomal dominant disease characterized by multisystemic developmental defects caused by <i>pathogenic variants such as patched-1</i> ( <i>PTCH1</i> ) gene variants and/or SUFU gene variants. The presence of either two main criteria or one major and two minor criteria are required for the diagnosis of Gorlin-Goltz syndrome. Recently, a major criterion for molecular confirmation has also been proposed. In this article, we report the case of an 80-year-old male who was admitted at our department for multiple brown-to-black papules and plaques on the entire body. He was diagnosed with Gorlin-Goltz syndrome with clinical, radiologic, and pathologic findings. While the diagnosis was made based on the clinical findings in general, confirmation of the genetic variants makes an ideal diagnosis and suggests a new treatment method for target therapy. We requested a genetic test of PTCH1 to ideally identify the molecular confirmation in the hedgehog signaling pathway. However, no pathogenic variants were found in the coding region of PTCH1, and no molecular confirmation was achieved.</p>\",\"PeriodicalId\":47543,\"journal\":{\"name\":\"Archives of Plastic Surgery-APS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411172/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Plastic Surgery-APS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2096-3536\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Plastic Surgery-APS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2096-3536","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

Gorlin-Goltz综合征,也称为痣样基底细胞癌综合征,是一种常染色体显性遗传疾病,其特征是由致病性变体如patched-1(PTCH1)基因变体和/或SUFU基因变体引起的多系统发育缺陷。戈尔林-戈尔茨综合征的诊断需要两个主要标准或一个主要标准和两个次要标准。最近,还提出了一个主要的分子确认标准。在这篇文章中,我们报告了一例80岁的男性,他因全身多发棕色至黑色丘疹和斑块而住进了我们的科室。根据临床、放射学和病理学检查结果,他被诊断为Gorlin-Goltz综合征。虽然诊断是基于一般的临床发现,但对基因变异的确认是一个理想的诊断,并为靶向治疗提供了一种新的治疗方法。我们要求对PTCH1进行基因测试,以理想地确定刺猬信号通路中的分子确认。然而,在PTCH1的编码区没有发现致病性变体,也没有得到分子证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Gorlin-Goltz Syndrome: A Case Report and Literature Review with <i>PTCH1</i> Gene Sequencing.

Gorlin-Goltz Syndrome: A Case Report and Literature Review with <i>PTCH1</i> Gene Sequencing.

Gorlin-Goltz Syndrome: A Case Report and Literature Review with <i>PTCH1</i> Gene Sequencing.

Gorlin-Goltz Syndrome: A Case Report and Literature Review with PTCH1 Gene Sequencing.

Gorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome, is an autosomal dominant disease characterized by multisystemic developmental defects caused by pathogenic variants such as patched-1 ( PTCH1 ) gene variants and/or SUFU gene variants. The presence of either two main criteria or one major and two minor criteria are required for the diagnosis of Gorlin-Goltz syndrome. Recently, a major criterion for molecular confirmation has also been proposed. In this article, we report the case of an 80-year-old male who was admitted at our department for multiple brown-to-black papules and plaques on the entire body. He was diagnosed with Gorlin-Goltz syndrome with clinical, radiologic, and pathologic findings. While the diagnosis was made based on the clinical findings in general, confirmation of the genetic variants makes an ideal diagnosis and suggests a new treatment method for target therapy. We requested a genetic test of PTCH1 to ideally identify the molecular confirmation in the hedgehog signaling pathway. However, no pathogenic variants were found in the coding region of PTCH1, and no molecular confirmation was achieved.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.10
自引率
6.70%
发文量
131
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信